NSE - Delayed Quote INR
Marksans Pharma Limited (MARKSANS.NS)
216.03
-12.34
(-5.40%)
At close: April 25 at 3:30:03 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
--
2,304,070
2,374,120
992,570
1,785,900
Investing Cash Flow
--
-1,408,400
-2,592,120
-843,910
-448,490
Financing Cash Flow
--
-687,270
1,978,290
795,110
-152,850
End Cash Position
--
4,032,770
3,824,370
2,064,060
2,121,830
Capital Expenditure
--
-2,088,380
-536,310
-463,300
-464,260
Issuance of Capital Stock
--
--
2,747,090
911,550
--
Issuance of Debt
--
--
52,960
225,520
--
Repayment of Debt
--
--
--
--
-1,025.15
Repurchase of Capital Stock
--
--
-451,660
--
--
Free Cash Flow
--
215,690
1,837,810
529,270
1,321,640
3/31/2021 - 7/19/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SMSPHARMA.NS SMS Pharmaceuticals Limited
240.35
-0.71%
SENORES.NS SENORES PHARMACEUTICALS L
517.05
-2.90%
SANOFICONR.NS SANOFI CONS HEALTHC IND L
4,939.00
+0.03%
KOPRAN.NS Kopran Limited
190.58
-4.16%
SANOFI.NS Sanofi India Limited
6,273.00
-4.51%
BMY Bristol-Myers Squibb Company
47.90
-1.62%
LLY Eli Lilly and Company
884.54
+2.89%